CHGA and neoplasm: Together with the previously described correlation of Chromogranin A expression by the tumor tissue with its serum level [23], our data might suggest that elevated NE serum markers in metastatic prostate cancer [14] may primarily reflect the metastatic, frequently poorly differentiated tumor burden [24,25,26].